DCGI

Covid Vaccine International travel

Centre issues SOPs for vaccination of persons undertaking international travel

On several representations received by Union Ministry of Health & Family Welfare for allowing administration of second dose of Covishield for such persons who have only taken first dose of Covishield and are seeking to undertake international travel for educational purposes or employment opportunities or as part of India’s contingent for Tokyo Olympic games, but …

Centre issues SOPs for vaccination of persons undertaking international travel Read More »

DIPCOVAN

DRDO develops COVID-19 antibody detection kit

Defence Institute of Physiology and Allied Sciences (DIPAS), a laboratory of Defence Research and Development Organisation (DRDO), has developed an antibody detection-based kit ‘DIPCOVAN’, the DIPAS-VDx COVID-19 IgG Antibody Microwell ELISA for sero-surveillance. The DIPCOVAN kit can detect both spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 …

DRDO develops COVID-19 antibody detection kit Read More »

DRDO

DRDO’s anti-COVID 2-DG drug approved by DCGI

The Defence Research and Development Organisation (DRDO’s) new anti COVID drug, approved by the Drug Controller General of India (DCGI). DRDO scientists said it is effective against different variants of the coronavirus and helps in bringing out patients out of oxygen support.  As per the scientist at the DRDO’s Institute of Nuclear Medicine and Allied …

DRDO’s anti-COVID 2-DG drug approved by DCGI Read More »

Zydus

DCGI approves emergency use of Zydus’s Virafin

Zydus Cadila received emergency use approval from the Drugs Controller General of India (DCGI) for the use of Virafin, Pegylated Interferon alpha- 2b(PegIFN) in treating moderate COVID-19COVID-19 infection in adults. infection in adults. A single dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients.  As per the release, …

DCGI approves emergency use of Zydus’s Virafin Read More »